Microarrays R Us - for the Moment

In this issue we take a close look at DNA microarrays, the current amore of biological and biomedical researchers. There's little reason to doubt that the infatuation will continue, at least for awhile. Microarrays are relatively inexpensive, powerful tools for assessing gene expression. On glass or plastic slides, thousands of known DNA sequences are printed, spotted or synthesized. mRNA is isolated from samples, often converted to cDNA and amplified, before hybridization on the slides. The

Written byRichard Gallagher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In this issue we take a close look at DNA microarrays, the current amore of biological and biomedical researchers. There's little reason to doubt that the infatuation will continue, at least for awhile.

Microarrays are relatively inexpensive, powerful tools for assessing gene expression. On glass or plastic slides, thousands of known DNA sequences are printed, spotted or synthesized. mRNA is isolated from samples, often converted to cDNA and amplified, before hybridization on the slides. The array is scanned to measure how much sample is bound to a particular region. Computer analysis generates gene expression profiles of samples, from which hypotheses are tested and conclusions drawn.

The first microarray experiment was described in 1995; in total, 100-150 other papers were published over the next four years (depending on the search criteria used). Since then, its popularity has mushroomed, with many hundreds of papers published each year since 2000.

That first experiment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies